Monoclonal Antibody
- All
- News
- Videos
-
New Asthma Treatment Offers Hope With Reduced Steroid Dependence
Research indicates that severe asthma can be managed effectively through biologic therapies, eliminating the need for additional high-dose inhaled steroids with potential significant side effects.
-
India To Get 20 More Doses Of Antibody From Australia To Treat Nipah
India will procure from Australia 20 more doses of monoclonal antibody for the treatment of Nipah virus infection, the Indian Council of Medical Research (ICMR) said on Friday.
-
India To Get These Antibodies From Australia For Nipah Treatment
India will procure from Australia 20 more doses of monoclonal antibody for the treatment of Nipah virus infection, ICMR DG Rajeev Bahl said on Friday.
-
Monoclonal Antibody, Only Treatment Against Nipah Infection, Reaches Kerala
The monoclonal antibody required to treat the Nipah virus infection has arrived in the state, Kerala said today.
-
Patients With High Covid Risk Least Likely To Get Monoclonal Antibodies: Study
According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the disease -- both across and within US states.
-
Omicron May Not Evade All Monoclonal Antibodies, Study Suggests
The Omicron variant of coronavirus may evade several, but not all, monoclonal antibodies used clinically to prevent patients from developing severe COVID-19, according to a laboratory study.
-
On Covid Antibody Therapy, Top Virologist: "Unethical, Unscientific"
Top virologist Dr Gagandeep Kang has called the prescription of monoclonal antibody therapy by the doctors in the private hospitals of the country for the treatment of Omicron variant of COVID-19 patients "unethical, immoral and unscientific".
-
Masks Not Recommended For Children Below 5 Years, Says Revised Guidelines
Use of antivirals or monoclonal antibodies is not recommended for those less than 18 years of age, irrespective of severity of Covid infection, the government said on Thursday.
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
European Union To Approve First Covid Antibody Drugs Amid Spike In Cases
The European Union drugs regulator is set to authorise the use of two monoclonal antibodies to treat COVID-19 patients in coming days, two EU sources told Reuters, in its first approvals of such therapies.
-
Monoclonal Antibody Treatment Combo Cuts Hospitalisation Among High-Risk Covid Patients: Study
A combination of 2 monoclonal antibody treatments keeps high-risk Covid patients out of the hospital when infected with mild to moderate disease, according to an observational study published in The Lancet's EClinicalMedicine journal.
-
"Symptoms Gone In A Day": Doctor On Antibody Cocktail To 40 In Hyderabad
As many as 40 Covid patients have taken a single-dose drug cocktail of monoclonal antibodies at Hyderabad's Asian Institute of Gastroenterology. "In 24 hours, they recovered from clinical symptoms like fever, malaise etc," said top doctor.
-
After New Antibody Therapy, 2 Covid Patients Discharged From Delhi Hospital In 12 Hours
Sir Ganga Ram Hospital of New Delhi has reported successful use of Monoclonal antibody in two Covid patients with fast progression of symptoms within the first seven days. Both patients recovered and were discharged with 12 hours.
-
Monoclonal Antibody Therapy Improved Parameters In 2 Covid Patients: Delhi Hospital
Clinical parameters of two COVID-19 patients improved significantly within 12 hours of administering monoclonal antibody therapy, doctors at Sir Ganga Ram Hospital in Delhi said on Wednesday.
-
Two Elderly Covid Patients, Who Got Antibody Therapy On June 1, Test -ve
Two Covid-positive senior citizens with heart complications, who were administered the monoclonal antibody therapy at a leading private facility in Delhi a week ago, have "tested negative" for the coronavirus infection.
-
New Asthma Treatment Offers Hope With Reduced Steroid Dependence
Research indicates that severe asthma can be managed effectively through biologic therapies, eliminating the need for additional high-dose inhaled steroids with potential significant side effects.
-
India To Get 20 More Doses Of Antibody From Australia To Treat Nipah
India will procure from Australia 20 more doses of monoclonal antibody for the treatment of Nipah virus infection, the Indian Council of Medical Research (ICMR) said on Friday.
-
India To Get These Antibodies From Australia For Nipah Treatment
India will procure from Australia 20 more doses of monoclonal antibody for the treatment of Nipah virus infection, ICMR DG Rajeev Bahl said on Friday.
-
Monoclonal Antibody, Only Treatment Against Nipah Infection, Reaches Kerala
The monoclonal antibody required to treat the Nipah virus infection has arrived in the state, Kerala said today.
-
Patients With High Covid Risk Least Likely To Get Monoclonal Antibodies: Study
According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the disease -- both across and within US states.
-
Omicron May Not Evade All Monoclonal Antibodies, Study Suggests
The Omicron variant of coronavirus may evade several, but not all, monoclonal antibodies used clinically to prevent patients from developing severe COVID-19, according to a laboratory study.
-
On Covid Antibody Therapy, Top Virologist: "Unethical, Unscientific"
Top virologist Dr Gagandeep Kang has called the prescription of monoclonal antibody therapy by the doctors in the private hospitals of the country for the treatment of Omicron variant of COVID-19 patients "unethical, immoral and unscientific".
-
Masks Not Recommended For Children Below 5 Years, Says Revised Guidelines
Use of antivirals or monoclonal antibodies is not recommended for those less than 18 years of age, irrespective of severity of Covid infection, the government said on Thursday.
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
European Union To Approve First Covid Antibody Drugs Amid Spike In Cases
The European Union drugs regulator is set to authorise the use of two monoclonal antibodies to treat COVID-19 patients in coming days, two EU sources told Reuters, in its first approvals of such therapies.
-
Monoclonal Antibody Treatment Combo Cuts Hospitalisation Among High-Risk Covid Patients: Study
A combination of 2 monoclonal antibody treatments keeps high-risk Covid patients out of the hospital when infected with mild to moderate disease, according to an observational study published in The Lancet's EClinicalMedicine journal.
-
"Symptoms Gone In A Day": Doctor On Antibody Cocktail To 40 In Hyderabad
As many as 40 Covid patients have taken a single-dose drug cocktail of monoclonal antibodies at Hyderabad's Asian Institute of Gastroenterology. "In 24 hours, they recovered from clinical symptoms like fever, malaise etc," said top doctor.
-
After New Antibody Therapy, 2 Covid Patients Discharged From Delhi Hospital In 12 Hours
Sir Ganga Ram Hospital of New Delhi has reported successful use of Monoclonal antibody in two Covid patients with fast progression of symptoms within the first seven days. Both patients recovered and were discharged with 12 hours.
-
Monoclonal Antibody Therapy Improved Parameters In 2 Covid Patients: Delhi Hospital
Clinical parameters of two COVID-19 patients improved significantly within 12 hours of administering monoclonal antibody therapy, doctors at Sir Ganga Ram Hospital in Delhi said on Wednesday.
-
Two Elderly Covid Patients, Who Got Antibody Therapy On June 1, Test -ve
Two Covid-positive senior citizens with heart complications, who were administered the monoclonal antibody therapy at a leading private facility in Delhi a week ago, have "tested negative" for the coronavirus infection.
